MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Circadian rhythm alterations in an in vitro cellular model of Spinocerebellar ataxia type 17

    F. Motolese, A. Casamassa, A. Vescovi, V. Di Lazzaro, J. Rosati, M. Marano (Rome, Italy)

    Objective: To study in vitro expression of circadian rhythm genes (CLOCK, BMAL) in fibroblasts and neural cells of SCA17 patients. Background: Spinocerebellar Ataxia 17 (SCA17)…
  • MDS Virtual Congress 2020

    Does “5-2-1” identify patients with suspected Advanced Parkinson’s Disease? Evidence of clinical accuracy from G7 countries

    A. Antonini, P. Odin, T. Henriksen, M. Soileau, R. Rodriguez-Cruz, A. Alobaidi, Y. Jalundhwala, P. Kandukuri, J.C Parra, K. Onuk, P. Kukreja, A. Gillespie, J. Pike, K.R Chaudhuri (North Chicago, IL, USA)

    Objective: Evaluate the psychometric properties of (i) the “5-2-1” criteria and (ii) consensus-driven clinical indicators of suspected advanced Parkinson’s disease (APD). Background: Recent consensus panel…
  • MDS Virtual Congress 2020

    The utility of single dose levodopa challenges in the management of Parkinson’s disease

    D. Tsui, D. Galea, N. Mahant, S. Kim, S. Babu, V. Fung (Sydney, Australia)

    Objective: To retrospectively review the clinical utility of single dose levodopa challenges in the management of Parkinson in a tertiary movement disorder clinic. Background: Acute…
  • MDS Virtual Congress 2020

    Cross-linguistic exploration of speech treatment for Parkinson’s disease: is a universal speech treatment approach plausible?

    C. Fox (Tucson, AZ, USA)

    Objective: Examine speech treatment outcomes in people with Parkinson’s disease (PD) across different languages to explore the plausibility of a universal speech treatment approach. Background:…
  • MDS Virtual Congress 2020

    The efficacy of traditional Mikkyo Buddhism meditation in stress management of Parkinson’s syndrome patients

    S. Murahashi, Y. Takeuchi, Y. Hara (Yatsushiro, Japan)

    Objective: To investigate the efficacy of Asokukan in stress management of Parkinson’s syndrome patients. Background: Stress management is very important in intractable neurological diseases. Currently,…
  • MDS Virtual Congress 2020

    Predictors of quality of life in Machado-Joseph disease: A longitudinal observational study

    I. Cunha, P. Silva, J. A Ribeiro, M. Santana, L. P Almeida, C. Januário (Coimbra, Portugal)

    Objective: Determine the influence of clinical symptoms on QoL in patients with Machado-Joseph disease (MJD). Background: MJD is a rare inherited neurodegenerative disorder. Its phenotypical expression…
  • MDS Virtual Congress 2020

    The Care Partner Perspective: Most Challenging Parkinson’s Symptoms

    A. Wallis, D. Perret (Miami, FL, USA)

    Objective: Our objective is to understand the impact that specific symptoms have on the care partners of people with Parkinson’s, considering gender (of both the…
  • MDS Virtual Congress 2020

    Recessive CWF19L1 mutations in a family with dystonia-ataxia syndrome

    S. Weber, M. Zech, S. Boesch, J. Winkelmann (Kassel, Germany)

    Objective: To enrich the limited clinical and genetic data of an extremely rare recessive ataxia subtype. Background: Advances in NGS techniques led to an increase…
  • MDS Virtual Congress 2020

    Endorsement of self-reported non-motor symptoms is associated with higher self-rated motor experiences of daily living in MDS-UPDRS part 2 in Parkinson’s disease

    A. Thomann, K. Taylor, F. Lipsmeier, D. Trundell, G. Pagano, S. Zolfaghari, R. Postuma (Basel, Switzerland)

    Objective: To quantify the extent to which self-perceived motor limitations (MDS-UPDRS part 2) relate to self-reported levels of non-motor symptom severity. Background: The MDS-UPDRS part…
  • MDS Virtual Congress 2020

    MDSGene Systematic Review: Genotype-Phenotype Relations for Hereditary Spastic Paraplegia Genes SPAST, ATL1 & REEP1

    C. Kang, J. Huang, R. Rajalingam, A. Rasheed, J. Zhang, Z. Walls, M. Hamed, M. Breza, S. Schaake, J. Massa, R. Massa, A. Shetty, C. Sue, R. Schule, F. Cambi, O. Suchowersky, F. Vulinovic, S. Petkovic, C. Klein, K. Lohmann, C. Marras, K. Kumar (St Leonards, Australia)

    Objective: To provide a comprehensive systematic review of the genotype-phenotype association in the most common three autosomal dominant genes of hereditary spastic paraplegia (HSP): SPAST,…
  • « Previous Page
  • 1
  • …
  • 145
  • 146
  • 147
  • 148
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley